IMU Biosciences
Pre-clinicalUnlocking the potential of the immune system. IMU's cutting-edge platform decodes complex immune challenges to drive breakthroughs and better health outcomes.
Founded
2021
Focus
ImmunologyAI / Machine Learning
About
Unlocking the potential of the immune system. IMU's cutting-edge platform decodes complex immune challenges to drive breakthroughs and better health outcomes.
Funding History
2Total raised: $17.8M
Series A$15MM VenturesJul 15, 2023
Seed$2.8MUndisclosedJan 15, 2022
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile